聚乙烯作为药物,gemfibrozil的载体,以海湾贝幼虫 (Argopecten irradians) 的作用
Charles Major1, Helen Poynton1, Juanita Urban-Rich1
1School for the Environment, University of Massachusetts Boston, Boston, MA 02125, USA.
Marine pollution bulletin
|July 19, 2025
概括
像聚乙烯珠子这样的微塑料可以携带心脏药物gemfibrozil,到海湾幼虫. 这种组合会增加幼虫死亡率,并对它们的发育产生负面影响,即使在低环境度下.
科学领域:
- 环境科学 环境科学
- 海洋生物学 海洋生物学
- 生态毒理学 生态毒理学
背景情况:
- 在全球范围内,微塑料和像gemfibrozil这样的药品在沿海地区被检测到.
- 米布罗齐尔是一种常用于治疗心脏病的药物.
- 海湾幼虫 (Argopecten irradians) 是一个脆弱的海洋物种.
研究的目的:
- 为了调查微塑料是否作为gemfibrozil向海湾幼虫的载体.
- 评估微塑料吸收的gemfibrozil对幼虫生存和发育的影响.
- 为了确定环保相关度的gemfibrozil对微塑料载体的影响.
主要方法:
- D阶段海湾幼虫暴露于带有或没有吸收的gemfibrozil的15微米聚烯珠.
- 在24小时内进行急性毒性测试.
- 幼虫脂质指数和死亡率评估.
- 暴露后生长期观察对生存,体型和脂质指数的长期影响.
主要成果:
- 聚乙烯珠子显著增加了幼虫的gemfibrozil吸收.
- 在暴露在聚烯珠和吸收的gemfibrozil的幼虫中观察到的最高死亡率,特别是在低度下.
- 在暴露于微塑料-gemfibrozil 载体的幼虫中显著降低脂质指数.
- 在成长阶段观察到对死亡率,体型和脂质指数的持续负面影响.
结论:
- 微塑料,特别是聚乙烯珠子,可以作为有效的载体来运输gemfibrozil到海湾幼虫.
- 即使在低环境度下,暴露于微塑料-gemfibrozil载体,也会显著增加幼虫死亡率,并损害发育.
- 这些发现凸显了海洋环境中微塑料和药品的联合存在所带来的生态毒理风险.
相关概念视频
01:21Drug Distribution: Tissue Binding
3.7K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
3.7K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.6K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.6K
01:20Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
738
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
738
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
336
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
336
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
167
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
167